ArticleInternational journal of oncology2018

Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol.

Shih-Ting Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.